Financial Summary (All financials)
| In millions, except per share items | Dec-31-04 | Dec-31-03 | Dec-31-02 | Dec-31-01 | Dec-31-00 | Dec-31-99 | Dec-31-98 |
| Revenues | | | | 85.9 | 66.7 | 60.0 | 95.0 |
| Revenue growth | | | | 28.9% | 11.1% | -36.9% | |
| Cost of goods sold | | | | 51.3 | 37.9 | 33.6 | 68.2 |
| Gross profit | | | | 34.6 | 28.8 | 26.4 | 26.8 |
| Gross margin | | | | 40.3% | 43.2% | 44.0% | 28.2% |
| Sales and marketing | | | | 15.8 | 10.7 | 11.1 | 11.8 |
| Research and development | | | | 12.3 | 7.0 | 5.1 | 5.1 |
| General and administrative | | | | 12.6 | 10.2 | 7.5 | 7.1 |
| EBIT | | | | -6.1 | 0.9 | 2.7 | 2.9 |
| EBIT margin | | | | -7.1% | 1.4% | 4.5% | 3.0% |
| Pre-tax income | | | | -1.5 | 3.8 | 2.2 | 1.1 |
| Income taxes | | | | 0.9 | 0.6 | 0.1 | 0.0 |
| Tax rate | | | | | 14.6% | 4.0% | 0.8% |
| Net income | | | | 0.0 | 0.0 | 0.0 | 0.0 |
| Net margin | | | | 0.0% | 0.0% | 0.0% | 0.0% |
| |
| Diluted EPS | | | | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares outstanding (diluted) | | | | 10,727.8 | 10,697.6 | 9,582.0 | 9,876.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|